| 101 |
17657173 | Effects of patupilone (epothilone B; EPO906), a novel chemotherapeutic agent, in hepatocellular carcinoma: an in vitro study. | 2006 |
1 |
| 102 |
15316750 | Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093). | 2005 Jan |
5 |
| 103 |
15643508 | Bcl-2 overexpression enhances in vitro sensitivity against docetaxel in non-small cell lung cancer. | 2005 Feb |
2 |
| 104 |
15773348 | [Gene therapy for breast cancer]. | 2005 Mar |
1 |
| 105 |
15955594 | Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells. | 2005 Sep |
2 |
| 106 |
14610615 | Activity of docetaxel in paclitaxel-resistant ovarian cancer cells. | 2004 Mar |
1 |
| 107 |
15060738 | Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023. | 2004 May |
2 |
| 108 |
12722676 | [Gene therapy for breast cancer]. | 2003 Apr |
3 |
| 109 |
14617793 | Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. | 2003 Nov |
1 |
| 110 |
11839680 | MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models. | 2002 Feb |
3 |
| 111 |
12008197 | Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933. | 2002 May |
1 |
| 112 |
12121008 | Medicinal chemistry and chemical biology of new generation taxane antitumor agents. | 2002 Apr-May |
2 |
| 113 |
11181682 | Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel. | 2001 Feb 15 |
3 |
| 114 |
10601617 | Clofazimine and B4121 sensitize an intrinsically resistant human colon cancer cell line to P-glycoprotein substrates. | 2000 Jan-Feb |
3 |
| 115 |
10639573 | NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy. | 2000 Feb |
2 |
| 116 |
9864431 | The chemosensitizing potential of GF120918 is independent of the magnitude of P-glycoprotein-mediated resistance to conventional chemotherapeutic agents in a small cell lung cancer line. | 1999 Jan-Feb |
3 |
| 117 |
10576649 | The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells. | 1999 Nov |
2 |
| 118 |
10665657 | Interaction of docetaxel ("Taxotere") with human P-glycoprotein. | 1999 Dec |
14 |
| 119 |
9062411 | Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis. | 1997 |
3 |
| 120 |
21544450 | P-glycoprotein-associated resistance to taxol and taxotere and its reversal by dexniguldipine-HCl, dexverapamil-HCl, or cyclosporin A. | 1996 May |
1 |
| 121 |
7896535 | Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro. | 1994 |
1 |
| 122 |
7945455 | Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. | 1994 Oct 7 |
2 |
| 123 |
8100632 | Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. | 1993 May |
1 |